MedTrace Logo

A Formative Study to Explore the Sensory Perceptions of Vaginal Product Users

NCT01334827 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2025-10-15

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to compare, contrast, and characterize the range of user perceptions and potential acceptability of three (3) topical vaginal microbicide dosage forms.

Conditions

  • Microbicide Delivery System Acceptability

Interventions

OTHER

high volume gel

4 mL HEC

OTHER

low volume gel

2 mL HEC

OTHER

vaginal film

1" x 2" intravaginal quick-dissolving film

Sponsors & Collaborators

  • ImQuest Pharmaceuticals, Inc.

    collaborator INDUSTRY

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • The Miriam Hospital

    lead OTHER

Principal Investigators

  • Robert Buckheit, PhD · ImQuest Pharmaceuticals

  • Kathleen Morrow, PhD · The Miriam Hospital

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01334827 on ClinicalTrials.gov